Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioSenic SA AGM Information 2017

Oct 13, 2017

3920_rns_2017-10-13_81e3d859-384c-4d68-8e9e-8499bb966ba4.pdf

AGM Information

Open in viewer

Opens in your device viewer

BONE THERAPEUTICS

LIMITED LIABILITY COMPANY HAVING MADE A PUBLIC APPEAL ON SAVINGS Rue Auguste Piccard 37 6041 Gosselies LER Charleroi 0882.015.654

(the Company)

INFORMATION CONCERNING THE RIGHTS OF SHAREHOLDERS TO ASK QUESTIONS ON THE OCCASION OF THE EXTRAORDINARY GENERAL MEETING OF THE COMPANY TO BE HELD ON 30 OCTOBER 2017 AT 11:45AM AT RUE DU FORT 24, 6000 CHARLEROI

Pursuant to article 540 of the Belgian Companies Code, the shareholders have the right to ask questions in writing to the directors prior to the general meeting that will be held on 30 October 2017.

The exercise of this right is subject to the fulfilment of the following two conditions:

  • being a shareholder of the Company at the registration date (on 16 October 2017 at midnight); and
  • having informed the Company of the intent to participate in the general meeting, pursuant to the provisions set out in the convocation notice.

These questions can be submitted prior to the general meeting by mail marked for the attention of Mrs Valérie Roels, Bone Therapeutics, rue Auguste Piccard 37, 6041 Gosselies, or by email to [email protected], or by fax to +32 2 529 59 93. They must be received by the Company on 24 October 2017 at 5:00 pm at the latest.

During the general meeting, the directors will answer the questions which have been raised by the shareholders (orally or in writing) on the items on the agenda, to the extent that the communication of data or facts is not potentially detrimental to the commercial interests of the Company or to the confidentiality undertakings of the Company or its directors.

The directors may give a global answer to different questions dealing with the same subject.